| Literature DB >> 36072194 |
Atif A Hashmi1, Khushbakht Rashid2, Rubia Ali2, Tanim Ud Dowlah3, Abrahim H Ali3, Muhammad Asad Diwan4, Umair Arshad Malik5, Muhammad Irfan6, Shamail Zia7, Adeel Ahmad8.
Abstract
Introduction Alopecia is a common dermatological condition with varied etiologies based on age, gender and geographic location. Non-cicatricial (non-scarring) alopecia is more common but often not biopsied. Alternatively, primary cicatricial (scarring) alopecia is diagnostically more challenging and more commonly biopsied to determine the etiology. In this study, we evaluated the clinicopathological characteristics of alopecia in our population. Methods We conducted a retrospective study at the Department of Histopathology, Liaquat National Hospital and Medical College, Pakistan. A total of 104 patients were enrolled in the study who underwent scalp biopsy for alopecia over a period of 11 years. Clinical data were obtained from clinical referral forms, which included age, sex of the patients and duration of the lesions. Three hematoxylin and eosin-stained tissue sections, along with periodic acid-Schiff (PAS), PAS with diastase and collagen stains were examined, and histopathological diagnosis was rendered. Results Our study demonstrated that alopecia was more prevalent among females, accounting for 73.1% of cases. Most of the patients belonged to the age group of <35 years (53.8%). The type of alopecia in 88.5% of the cases was scarring, while there were 11.5% cases of non-scarring alopecia. The most common diagnoses were discoid lupus erythematosus (DLE) (23.1%) and pseudopelade of Brocq (PB) (23.1%), followed by lichen planopilaris (LPP) (15.4%). A significant association was noted between the histological features and the diagnosis, as epidermal atrophy was the most common histological feature in most cases of DLE, followed by periadnexal infiltrates, lymphocytic infiltrates, follicular plugging and basement membrane thickening. In LPP, the most common histological features were perifollicular infiltrates and fibrosis. In PB, the frequently recurring histological features in most cases were the loss of sebaceous glands, dermal fibrosis and epidermal thinning. Conclusion In this study, we demonstrated the key role of skin punch biopsy and histology in determining the accurate etiology of scarring alopecia. We found discoid lupus erythematosus and pseudopelade of Brocq to be the most common causes of scarring alopecia, followed by lichen planopilaris.Entities:
Keywords: discoid lupus erythematosus; lichen planopilaris (lpp); non-scarring alopecia; pseudopelade of brocq; scarring alopecia
Year: 2022 PMID: 36072194 PMCID: PMC9440352 DOI: 10.7759/cureus.27661
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Clinicopathological features of population under study
SD: standard deviation.
| Clinicopathological features | Values |
| Gender | |
| Male, n (%) | 28 (26.9) |
| Female, n (%) | 76 (73.1) |
| Age (years) | |
| Mean±SD | 37.54±14.08 |
| Age groups | |
| ≤35 years, n (%) | 56 (53.8) |
| 36-50 years, n (%) | 28 (26.9) |
| >50 years, n (%) | 20 (19.2) |
| Duration of symptoms | |
| Mean±SD | 32.12±29.24 |
| Duration of symptoms groups | |
| ≤36 months, n (%) | 72 (69.2) |
| >36 months, n (%) | 32 (30.8) |
| Diagnosis | |
| Lichen planopilaris, n (%) | 16 (15.4) |
| Discoid lupus erythematosus, n (%) | 24 (23.1) |
| Pseudopelade of Brocq, n (%) | 24 (23.1) |
| Folliculitis decalvans, n (%) | 4 (3.8) |
| Acute suppurative folliculitis, n (%) | 4 (3.8) |
| Pityrosporum folliculitis, n (%) | 4 (3.8) |
| Pityriasis versicolor, n (%) | 4 (3.8) |
| Lupus panniculitis, n (%) | 4 (3.8) |
| Trichotillomania, n (%) | 4 (3.8) |
| Chronic non-specific folliculitis, n (%) | 4 (3.8) |
| Lichen sclerosus, n (%) | 4 (3.8) |
| Nodular prurigo, n (%) | 4 (3.8) |
| Alopecia areata, n (%) | 4 (3.8) |
| Alopecia type | |
| Scarring, n (%) | 92 (88.5) |
| Non-scarring, n (%) | 12 (11.5) |
Histopathological findings in skin biopsy specimens
| Histopathological findings | Values |
| Epidermal atrophy, n (%) | 32 (30.8) |
| Follicular plugging, n (%) | 28 (26.9) |
| Epidermal thinning, n (%) | 20 (19.2) |
| Flattening of rete ridges, n (%) | 16 (15.4) |
| Acanthosis, n (%) | 4 (3.8) |
| Hyperkeratosis, n (%) | 20 (19.2) |
| Spongiosis, n (%) | 4 (3.8) |
| Subcorneal pustules, n (%) | 4 (3.8) |
| Parakeratosis, n (%) | 12 (11.5) |
| Neutrophilic exocytosis, n (%) | 4 (3.8) |
| Lymphocytic exocytosis, n (%) | 4 (3.8) |
| Vacuolar interface changes, n (%) | 20 (19.2) |
| Basement membrane thickening, n (%) | 12 (11.5) |
| Dermal mucin, n (%) | 8 (7.7) |
| Dermal granulomas, n (%) | 4 (3.8) |
| Neutrophilic infiltrates, n (%) | 4 (3.8) |
| Eosinophilic infiltrates, n (%) | 4 (3.8) |
| Lymphocytic infiltrates, n (%) | 44 (42.3) |
| Histiocytic infiltrates, n (%) | 12 (11.5) |
| Plasmacytic infiltrates, n (%) | 12 (11.5) |
| Perivascular infiltrates, n (%) | 40 (38.5) |
| Periadnexal infiltrates, n (%) | 24 (23.1) |
| Perifollicular infiltrates, n (%) | 28 (26.9) |
| Dermal edema, n (%) | 16 (15.4) |
| Dermal fibrosis, n (%) | 20 (19.2) |
| Loss of sebaceous glands, n (%) | 36 (34.6) |
| Loss of hair follicles, n (%) | 16 (15.4) |
| Perifollicular fibrosis, n (%) | 32 (30.8) |
| Pigment incontinence, n (%) | 12 (11.5) |
| Loss of elastic fibers, n (%) | 8 (7.7) |
Association of clinical features with the diagnosis
*p-value significant as <0.05.
| Diagnosis | Values | ||||||
| Gender | Age (years) | Duration of symptoms | |||||
| Male | Female | ≤35 years | 36-50 years | >50 years | ≤36 months | >36 months | |
| Lichen planopilaris, n (%) | 4 (25) | 12 (75) | 4 (25) | 4 (25) | 8 (50) | 4 (25) | 12 (75) |
| Discoid lupus erythematosus, n (%) | 4 (16.7) | 20 (83.3) | 16 (66.7) | 8 (33.3) | 0 (0) | 20 (83.3) | 4 (16.7) |
| Pseudopelade of Brocq, n (%) | 0 (0) | 24 (100) | 12 (50) | 4 (16.7) | 8 (33.3) | 20 (83.3) | 4 (16.7) |
| Folliculitis decalvans, n (%) | 0 (0) | 4 (100) | 4 (100) | 0 (0) | 0 (0) | 4 (100) | 0 (0) |
| Acute suppurative folliculitis, n (%) | 4 (100) | 0 (0) | 4( 100) | 0 (0) | 0 (0) | 0 (0) | 4 (100) |
| Pityrosporum folliculitis, n (%) | 0 (0) | 4 (100) | 0 (0) | 4 (100) | 0 (0) | 4 (100) | 0 (0) |
| Pityriasis versicolor, n (%) | 4 (100) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | 0 (0) | 4 (100) |
| Lupus panniculitis, n (%) | 0 (0) | 4 (100) | 4 (100) | 0 (0) | 0 (0) | 4 (100) | 0 (0) |
| Trichotillomania, n (%) | 4 (100) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | 4 (100) | 0 (0) |
| Chronic non-specific folliculitis, n (%) | 4 (100) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | 4 (100) | 0 (0) |
| Lichen sclerosus, n (%) | 0 (0) | 4 (100) | 0 (0) | 4 (100) | 0 (0) | 4 (100) | 0 (0) |
| Nodular prurigo, n (%) | 4 (100) | 0 (0) | 0 (0) | 0 (0) | 4 (100) | 4 (100) | 0 (0) |
| Alopecia areata, n (%) | 0 (0) | 4 (100) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | 4 (100) |
| p-value<0.001* | p-value<0.001* | p-value<0.001* | |||||
| Alopecia type | |||||||
| Scarring, n (%) | 20 (21.7) | 72 (78.3) | 48 (52.2) | 24 (26.1) | 20 (21.7) | 68 (73.9) | 24 (26.1) |
| Non-scarring, n (%) | 8 (66.7) | 4 (33.3) | 8 (66.7) | 4 (33.3) | 0 (0) | 4 (33.3) | 8 (66.7) |
| p-value<0.05* | p-value=0.203 | p-value<0.05* | |||||
Association of histopathological findings with the diagnosis
*p-value significant as <0.05.
| Histopathological findings | Values | p-value | ||||||||||||
| Lichen planopilaris | Discoid lupus erythematosus | Pseudopelade of Brocq | Folliculitis decalvans | Acute suppurative folliculitis | Pityrosporum folliculitis | Pityriasis versicolor | Lupus panniculitis | Trichotillomania | Chronic non-specific folliculitis | Lichen sclerosus | Nodular prurigo | Alopecia areata | ||
| Epidermal atrophy, n (%) | 0 (0) | 24 (75) | 8 (25) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Follicular plugging, n (%) | 0 (0) | 12 (42.9) | 4 (14.3) | 0 (0) | 0 (0) | 4 (14.3) | 0 (0) | 4 (14.3) | 4 (14.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Epidermal thinning, n (%) | 0 (0) | 0 (0) | 12 (60) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (20) | 0 (0) | 0 (0) | 4 (20) | 0 (0) | 0 (0) | <0.001* |
| Flattening of rete ridges, n (%) | 0 (0) | 8 (50) | 8 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.12 |
| Acanthosis, n (%) | 4 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.17 |
| Hyperkeratosis, n (%) | 4 (20) | 0 (0) | 4 (20) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (20) | 0 (0) | 4 (20) | 0 (0) | 0 (0) | <0.001* |
| Spongiosis, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Subcorneal pustules, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Parakeratosis, n (%) | 0 (0) | 4 (33.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (33.3) | 0 (0) | 0 (0) | 4 (33.3) | 0 (0) | <0.001* |
| Neutrophilic exocytosis, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Lymphocytic exocytosis, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | <0.001* |
| Vacuolar interface changes, n (%) | 4 (20) | 8 (40) | 8 (40) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Basement membrane thickening, n (%) | 0 (0) | 12 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Dermal mucin, n (%) | 0 (0) | 8 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Dermal granulomas, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Neutrophilic infiltrates, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | <0.001* |
| Eosinophilic infiltrates, n (%) | 4 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Lymphocytic Infiltrates, n (%) | 8 (18.2) | 16 (36.4) | 4 (9.1) | 4 (9.1) | 0 (0) | 0 (0) | 0 (0) | 4 (9.1) | 0 (0) | 0 (0) | 0 (0) | 4 (9.1) | 4 (9.1) | <0.001* |
| Histiocytic infiltrates, n (%) | 0 (0) | 4 (33.3) | 0 (0) | 4 (33.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (33.3) | 0 (0) | <0.001* |
| Plasmacytic Infiltrates, n (%) | 0 (0) | 4 (33.3) | 0 (0) | 4 (33.3) | 0 (0) | 0 (0) | 0 (0) | 4 (33.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Perivascular infiltrates, n (%) | 4 (10) | 12 (30) | 4 (10) | 0 (0) | 4 (10) | 0 (0) | 4 (10) | 4 (10) | 0 (0) | 0 (0) | 0 (0) | 4 (10) | 4 (10) | <0.001* |
| Periadnexal infiltrates, n (%) | 0 (0) | 16 (66.7) | 0 (0) | 0 (0) | 4 (16.7) | 0 (0) | 0 (0) | 4 (16.7) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Perifollicular infiltrates, n (%) | 12 (42.9) | 8 (28.6) | 0 (0) | 0 (0) | 0 (0) | 4 (14.3) | 4 (14.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001 |
| Dermal edema, n (%) | 0 (0) | 8 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (25) | 0 (0) | 0 (0) | 4 (25) | 0 (0) | 0 (0) | <0.001* |
| Dermal fibrosis, n (%) | 0 (0) | 0 (0) | 12 (60) | 4 (20) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (25) | 0 (0) | <0.001* |
| Loss of sebaceous glands, n (%) | 8 (22.2) | 4 (11.1) | 20 (55.6) | 4 (11.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001 |
| Loss of hair follicles, n (%) | 8 (50) | 0 (0) | 4 (25) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (25) | <0.001* |
| Perifollicular fibrosis, n (%) | 12 (37.5) | 4 (12.5) | 8 (25) | 4 (12.5) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (12.5) | <0.001* |
| Pigment incontinence, n (%) | 4 (33.3) | 4 (33.3) | 4(33.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.99 |
| Loss of elastic fibers, n (%) | 8 (100) | 0 (0) | 0(0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | <0.001* |
| Alopecia type | ||||||||||||||
| Scarring, n (%) | 16 (17.4) | 24 (26.1) | 24 (26.1) | 4 (4.3) | 4 (4.3) | 4 (4.3) | 0 (0) | 4 (4.3) | 0 (0) | 4 (4.3) | 4 (4.3) | 4 (4.3) | 0 (0) | <0.001* |
| Non-scarring, n (%) | 0 (0) | 0 (0) | 0(0) | 0 (0) | 0 (0) | 0 (0) | 4 (33.3) | 0 (0) | 4 (33.3) | 0 (0) | 0 (0) | 0 (0) | 4 (33.3) | |